Loading stock data…
$168.96-0.76 (-0.45%)
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.
Balchem Corporation in the Basic Materials sector is trading at $168.96 with a market capitalization of $5.4B. Wall Street consensus targets $209.25 (4 analysts), implying a +23.8% move over the next 12 months. The stock is currently 8% below its 52-week high of $183.90, remaining 0.3% above its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $270.71M↑ | $263.62M↓ | $267.56M↑ | $255.47M |
| Gross Profit | — | $101.08M↑ | $93.90M↓ | $95.45M↑ | $93.11M |
| Operating Income | — | $55.63M↑ | $52.29M↓ | $54.58M↑ | $51.44M |
| Net Income | — | $40.28M↑ | $39.23M↓ | $40.29M↑ | $38.28M |
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It o...